- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03864003
Community Health Workers and Teleaudiology as a Culturally-relevant Approach to Improving Access to Hearing Health Care
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arizona
-
Nogales, Arizona, United States, 85621
- Mariposa Community Health Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Bilateral hearing loss within the fitting range of study hearing aids
Exclusion Criteria:
- Medically unqualified to receive hearing aids
- Current hearing aid user
- Cognitively impaired
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
Participants randomized to the experimental group will receive hearing aid fitting and verification services via teleaudiology with local, hands-on support from a Community Health Worker.
|
In this project, remote hearing aid fittings will be delivered by an audiologist with patient-site support from a local facilitator for a cohort of older adults (>50 years) from a rural area that has been identified as under-resourced for hearing health care.
|
|
Active Comparator: Control Group
Participants randomized to the control group will receive hearing aid fitting and verification services via teleaudiology with local, hands-on support from a non-Community Health Worker (undergraduate student in Speech, Language, and Hearing Sciences).
|
In this project, remote hearing aid fittings will be delivered by an audiologist with patient-site support from a local facilitator for a cohort of older adults (>50 years) from a rural area that has been identified as under-resourced for hearing health care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-efficacy: The Self-Efficacy for Situational Communication Management Questionnaire
Time Frame: Baseline, 2 weeks, 6 weeks, and 12 weeks after hearing aid fitting
|
The Self-Efficacy for Situational Communication Management Questionnaire (Jennings, 2005; Jennings et al, 2014) measures self-perceived hearing ability and hearing self-efficacy, or a participant's beliefs in their ability to manage communication with acquired hearing loss. The SESMQ contains 20 situations that are rated on two scales, hearing ability and perceived self-efficacy. Participants respond on a Likert scale from 0 (not well at all) to 10 (very well) to how well they can hear and how well they can manage in each situation. Total scores on each scale range from 0-200, with higher scores representing better perceived self-efficacy and better hearing ability. The two scales are scored and reported separately. We will evaluate the differences in SESMQ scores between experimental and control groups at 2-weeks post hearing aid fitting. Analyses will utilize baseline data and follow-up analyses will occur for 6-week and 12-week timepoints. |
Baseline, 2 weeks, 6 weeks, and 12 weeks after hearing aid fitting
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hearing aid benefit
Time Frame: Baseline, 6 weeks, and 14 weeks after hearing aid fitting
|
The Effectiveness of Auditory Rehabilitation (Yueh et al., 2005; EAR) is a subjective scale of hearing aid function and quality of life. The first set of questions is administered before and after the hearing aid fitting, and relates to hearing concerns, including listening in quiet and other situations. The second set of questions relates to functioning with the hearing device, such as fit and convenience, and is administered after the hearing aid fitting. We will evaluate the differences in inner EAR scores between experimental and control groups at 6-weeks post hearing aid fitting. Analyses will utilize baseline data where appropriate and follow-up analyses will occur for 6-week and 12-week timepoints. Participants are asked to respond to statements on a five-point scale (i.e. very poor, poor, so-so, good, very good). Each answer is awarded a point. Higher cumulative scores indicate better benefit. |
Baseline, 6 weeks, and 14 weeks after hearing aid fitting
|
|
Satisfaction with teleaudiology service delivery
Time Frame: 2 weeks after hearing aid fitting
|
Telehealth Satisfaction Scale (TeSS) The TeSS is a 10-item scale probing satisfaction with telehealth services. Responses are on a 4-point likert scale (Excellent, good, poor, fair). Higher cumulative scores represent better satisfaction. |
2 weeks after hearing aid fitting
|
|
Qualitative outcomes via semi-structured interviews
Time Frame: 14 weeks after hearing aid fitting
|
Qualitative outcomes will target participants' subjective experience on access to hearing health care, self-efficacy, benefit, and satisfaction with service delivery and hearing aids.
|
14 weeks after hearing aid fitting
|
|
Average hours of hearing aid usage per day
Time Frame: 2 weeks, 6 weeks, 14 weeks after hearing aid fitting
|
We will ask participants the approximate average hours per day they use their hearing aid.
This information will also be collected from the hearing aid programming software.
|
2 weeks, 6 weeks, 14 weeks after hearing aid fitting
|
|
Subjective hearing aid benefit
Time Frame: 2 weeks, 6 weeks, 14 weeks after hearing aid fitting
|
Subjective hearing aid benefit will also be measured using a patient reported outcome measure, the International Outcome Inventory for Hearing Aids (IOI-HA).
Participants are asked to respond to seven questions on their experience with their hearing aids.
Questions on the IOI-HA are on a 5-point Likert-type scale.
Cumulative scores range from zero to 35.
Higher scores represent better benefit.
|
2 weeks, 6 weeks, 14 weeks after hearing aid fitting
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laura S Coco, AuD, University of Arizona
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1F32DC017081 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Oticon MedicalCompletedEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Truway Health, Inc.Enrolling by invitationSensorineural Hearing Loss | Tinnitus | Sudden Hearing Loss | Acoustic Trauma | Inner Ear Injury | Noise-Induced Hearing Loss | Vestibular DysfunctionUnited States
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on Community Health Workers and Teleaudiology as a Culturally-Relevant Approach to Improving Access to Hearing Health Care
-
Children's Mercy Hospital Kansas CityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsActive, not recruitingChild Obesity | Social Determinants of HealthUnited States
-
Assistance Publique Hopitaux De MarseilleNot yet recruitingQuality of Life | Mental Health | Sexual Violence | Physical Health | Refugee Health | Access to Recommended HealthcareFrance
-
Aga Khan UniversityUnited Nations; Global Affairs CanadaRecruitingReproductive Behavior, Family Planning ServicesPakistan
-
Johns Hopkins UniversityMaryland Cigarette Restitution Fund; WalgreensCompleted
-
Giovanna ZamboniUniversity of Florence; Fondazione Don Carlo Gnocchi Onlus; University of GenovaRecruitingApathy | Apathy in DementiaItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
Amplifi Vascular, Inc.RecruitingEnd Stage Kidney Disease (ESRD)United States
-
Anupama Raghuram MDGilead Sciences; University of LouisvilleNot yet recruiting
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); University of South FloridaActive, not recruitingBreast Cancer | Colorectal Cancer | Prostate Cancer | Endometrial Cancer | Inherited Cancer SyndromeUnited States
-
Queen Fabiola Children's University HospitalBrugmann University Hospital; Erasme University Hospital; Université Libre de... and other collaboratorsCompletedMental Health | Mental Disorder in Adolescence | Transitional CareBelgium